Movicol Ease

Macrogol 3350, the active ingredient in Movicol Ease, is an osmotic laxative presented as an oral powder for solution for oral use. It is used to relieve constipation in adults and children when other measures are insufficient. GNH USA supplies Movicol Ease as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Ease, an osmotic laxative, works within the gastrointestinal tract to treat various forms of constipation. - Constipation: softens stool and facilitates regular bowel movements. - Chronic constipation: provides long‑term relief for patients with persistent bowel irregularities. - Opioid‑induced constipation: counteracts reduced gut motility caused by opioid therapy.

Movicol Ease may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Nausea: feeling of sickness or urge to vomit. - Diarrhoea: loose, watery stools occurring more frequently. - Flatulence: excess gas in the digestive tract. - Stomach cramps: intermittent painful contractions of the abdomen.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent abdominal pain: ongoing severe discomfort. - Rectal bleeding: presence of blood in stool indicating possible injury.

Before using Movicol Ease, consider the following safety measures. - Assess renal function: ensure adequate kidney performance before initiating therapy. - Monitor electrolytes: check sodium, potassium and chloride levels during prolonged use. - Evaluate fluid status: maintain adequate hydration to prevent dehydration. - Use with caution in the elderly: increased susceptibility to fluid and electrolyte shifts. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Movicol Ease can interact with other medicines, affecting their absorption or electrolyte balance.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity due to altered renal clearance. - Digoxin: potential for reduced absorption leading to subtherapeutic levels.

Moderate Interactions (Monitor Closely): - Antacids containing aluminium or magnesium: may reduce laxative effectiveness. - Diuretics: heightened risk of electrolyte disturbances, especially potassium loss. - Oral antibiotics: possible decreased absorption, monitor therapeutic response.